0001179110-17-010704.txt : 20170726
0001179110-17-010704.hdr.sgml : 20170726
20170726163139
ACCESSION NUMBER: 0001179110-17-010704
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170725
FILED AS OF DATE: 20170726
DATE AS OF CHANGE: 20170726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grunberg Gregory
CENTRAL INDEX KEY: 0001711080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 17983265
MAIL ADDRESS:
STREET 1: 100 BEAVER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
edgar.xml
FORM 4 -
X0306
4
2017-07-25
0
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001711080
Grunberg Gregory
C/O KALA PHARMACEUTICALS, INC.
100 BEAVER STREET, SUITE 201
WALTHAM
MA
02453
1
0
0
0
Common Stock
2017-07-25
4
C
0
2055946
A
2055946
I
By Longitude Venture Partners II, L.P.
Common Stock
2017-07-25
4
P
0
215000
15
A
2270946
I
By Longitude Venture Partners II, L.P.
Series C Preferred Stock
2017-07-25
4
C
0
10707985
0
D
Common Stock
2055946
0
I
By Longitude Venture Partners II, L.P.
The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
These shares are held by Longitude Venture Partners II, L.P. The Reporting Person is a member of Longitude Capital Partners II, LLC, the general partner of Longitude Venture Partners II, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Includes 215,000 shares of Common Stock acquired by Longitude Venture Partners, II, L.P in the Issuer's initial public offering.
These shares were held by Longitude Venture Partners II, L.P. The Reporting Person is a member of Longitude Capital Partners II, LLC, the general partner of Longitude Venture Partners II, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
/s/ Mary Reumuth, Attorney-in-Fact
2017-07-26